As of January 2025, GeneReach Biotechnology has a market cap of $47.44M. This makes GeneReach Biotechnology the world's 23598th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $66.77M | -3.68% |
2023 | $69.32M | -40.23% |
2022 | $115.97M | -27.31% |
2021 | $159.55M | -27.82% |
2020 | $221.03M | 91.85% |
2019 | $115.21M | 74.87% |
2018 | $65.88M | 96.94% |
2017 | $33.45M | -2.00% |
2016 | $34.14M | -37.11% |
2015 | $54.28M | -41.33% |
2014 | $92.51M | 20.44% |
2013 | $76.81M | 0.00% |
2012 | $76.81M | - |